Berberine inhibits angiogenic potential of Hep G2 cell line through VEGF down-regulation in vitro

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 1, 2011, Pages 179-185

  Jie, Shenghua ^a   Li, Huiyu ^a   Tian, Yuan ^a   Guo, Dongmei ^a   Zhu, Jiang ^a   Gao, Shaoyang ^a   Jiang, Li ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Angiogenesis; Berberine; HCC; Vascular endothelial growth factor

Indexed keywords

BERBERINE; CHOLECYSTOKININ OCTAPEPTIDE; MATRIGEL; MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN 121; VASCULOTROPIN 165;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; ARTICLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN HEPG2; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 78650400672     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06389.x     Document Type: Article

References (18)

1. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999; 353: 1253-7.
2. Simonetti RG, Liberati A, Angiolini C, Pagliaro L. Treatment of hepatocellular carcinoma: a systemic review of randomized controlled trials. Ann. Oncol. 1997; 8: 117-36.
3. Lu N, Gao Y, Ling Y et al. Wogonin suppresses tumor growth in vivo and VEGF-induced angiogenesis through inhibiting tyrosine phosphorylation of VEGFR2. Life Sci. 2008; 82: 956-63.
4. Schmeller T, Latz-Brüning B, Wink M. Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defence against microorganisms and herbivores. Phytochemistry 1997; 44: 257-66.
5. Kuo CL, Chi CW, Liu TY. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett. 2004; 203: 127-37.
6. Jun T, Yibin F, Saiwah T, Ning W, Robert C, Youwei W. Berberine and coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J. Ethnopharmacol. 2009; 126: 5-17.
7. Poon RT, Ho JW, Tong CS, Lau C, Ng IO, Fan ST. Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma. Br. J. Surg. 2004; 91: 1354-60.
8. Lin S, Tsai SC, Lee CC, Wang BW, Liou JY, Shyu KG. Berberine inhibits HIF-1α expression via enhanced proteolysis. Mol. Pharmacol. 2004; 66: 612-19.
9. Ma J, Sawai H, Matsuo Y et al. Interleukin-1α enhances angiogenesis and is associated with iiver metastatic potential in human gastric cancer cell lines. J. Surg. Res. 2008; 148: 197-204.
10. Poon RT, Lau CP, Ho JW, Yu WC, Fan ST, Wong J. Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma. Clin. Cancer Res. 2003; 9: 5339-45.
11. Li BX, Yang BF, Zhou J et al. Inhibitory effects of berberine on IK1, IK and HERG channels of cardiac myocytes. Acta Pharmacol. Sin. 2001; 22: 125-31.
12. Li H, Liu L, Guo T et al. Expression and functional role of HERG1, K+ channels in leukemic cells and leukemic stem cells. J. Huazhong Univ. Sci. Technol. Med. Sci. 2007; 27: 257-60.
13. Li H, Liu L, Guo L et al. HERG K+ channel expression in CD34+/CD38-/CD123 (high) cells and primary leukemia cells and analysis of its regulation in leukemia cells. Int. J. Hematol. 2008; 87: 387-92.
14. Jie S, Li H. Expression of HERG K+ channels in BEL-7402 cell. Chin. J. Integr.Traditional Western Med. Dig. 2007; 15: 313-15.
15. Pillozzi S, Brizzi MF, Bernabei PA et al. VEGFR-1 (FLT-1), beta1 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome. Blood 2007; 110: 1238-50.
16. Li H, Du YM, Guo L et al. The role of hERG1 K+ channels and a functional link between hERG1 K+ channels and SDF-1 in acute leukemic cell migration. Exp. Cell Res. 2009; 315: 2256-64.
17. Li H, Guo L, Jie S et al. Berberine inhibits SDF-1-induced AML cells and leukemic stem cells migration via regulation of SDF-1 level in bone marrow stromal cells. Biomed. Pharmacother. 2008; 62: 573-8.
18. Masi A, Becchetti A, Restano-Cassulini R et al. hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines. Br. J. Cancer 2005; 93: 781-92.